CAMP4 THERAPEUTICS Company Insiders
| CAMP Stock | USD 5.41 0.37 6.40% |
CAMP4 THERAPEUTICS employs about 58 people. The company is managed by 27 executives with a total tenure of roughly 16 years, averaging almost 0.0 years of service per executive, having 2.15 employees per reported executive. Discussion of CAMP4 THERAPEUTICS's management performance can provide insight into the enterprise performance.
CAMP4 THERAPEUTICS's Insider Buying Vs Selling
50
Selling | Buying |
Latest Trades
| 2024-10-15 | Polaris Management Co. Vii, L. | Acquired 909090 @ 11 | View | ||
| 2024-06-05 | Jason Cohenour | Disposed 8640 @ 0.83 | View |
Monitoring CAMP4 THERAPEUTICS's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
CAMP4 |
CAMP4 THERAPEUTICS Management Team Effectiveness
As of 11/25/2024, Return On Tangible Assets is likely to grow to -0.22. In addition to that, Return On Capital Employed is likely to drop to -0.05. At this time, CAMP4 THERAPEUTICS's Non Current Liabilities Total is relatively stable compared to the past year. As of 11/25/2024, Non Current Liabilities Other is likely to grow to about 91.3 K, while Total Current Liabilities is likely to drop slightly above 7.4 M. CAMP4 THERAPEUTICS's management efficiency ratios could be used to measure how well CAMP4 THERAPEUTICS manages its routine affairs as well as how well it operates its assets and liabilities.As of 11/25/2024, Common Stock Shares Outstanding is likely to grow to about 39.3 M
CAMP4 THERAPEUTICS Workforce Comparison
CAMP4 THERAPEUTICS PORATION is rated below average in number of employees category among its peers. The total workforce of Information Technology industry is currently estimated at about 40,856. CAMP4 THERAPEUTICS adds roughly 58.0 in number of employees claiming only tiny portion of equities under Information Technology industry.
CAMP4 THERAPEUTICS Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CAMP4 THERAPEUTICS insiders, such as employees or executives, is commonly permitted as long as it does not rely on CAMP4 THERAPEUTICS's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, CAMP4 THERAPEUTICS insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2024-03-01 | 1.0 | 3 | 3 | 73,042 | 12,296 |
| 2023-12-01 | 1.0 | 2 | 2 | 183,167 | 5,746 |
| 2023-09-01 | 1.0 | 13 | 13 | 752,295 | 73,818 |
| 2023-06-01 | 0.8889 | 16 | 18 | 275,923 | 161,399 |
| 2023-03-01 | 0.6429 | 9 | 14 | 331,270 | 34,453 |
| 2022-12-01 | 1.3333 | 20 | 15 | 675,612 | 18,799 |
| 2022-09-01 | 1.0 | 30 | 30 | 1,769,849 | 91,856 |
| 2022-06-01 | 0.5294 | 9 | 17 | 625,665 | 340,963 |
| 2021-12-01 | 1.0 | 2 | 2 | 2,500 | 2,691 |
| 2021-09-01 | 1.2308 | 16 | 13 | 267,302 | 52,392 |
| 2021-06-01 | 1.125 | 9 | 8 | 62,633 | 59,467 |
| 2021-03-01 | 1.5 | 3 | 2 | 13,500 | 17,228 |
| 2020-12-01 | 1.5 | 3 | 2 | 3,500 | 2,691 |
| 2020-09-01 | 1.6154 | 21 | 13 | 345,378 | 30,395 |
| 2020-06-01 | 1.0 | 4 | 4 | 44,000 | 78,433 |
| 2020-03-01 | 0.5 | 1 | 2 | 30,000 | 60,000 |
| 2019-09-01 | 2.4286 | 17 | 7 | 521,553 | 36,586 |
| 2019-06-01 | 6.0 | 6 | 1 | 51,422 | 20,000 |
| 2018-12-01 | 0.25 | 2 | 8 | 11,000 | 32,000 |
| 2018-09-01 | 1.3077 | 17 | 13 | 267,271 | 50,121 |
| 2018-06-01 | 0.5 | 3 | 6 | 37,500 | 75,000 |
| 2018-03-01 | 0.4545 | 5 | 11 | 25,500 | 56,000 |
| 2017-12-01 | 0.2308 | 3 | 13 | 12,000 | 73,833 |
| 2017-09-01 | 1.5833 | 19 | 12 | 297,746 | 35,541 |
| 2017-06-01 | 0.4444 | 4 | 9 | 45,000 | 100,000 |
| 2017-03-01 | 0.4545 | 5 | 11 | 33,600 | 98,899 |
| 2016-12-01 | 0.375 | 3 | 8 | 12,386 | 35,318 |
| 2016-09-01 | 1.5833 | 19 | 12 | 395,928 | 53,546 |
| 2016-06-01 | 1.0 | 6 | 6 | 39,500 | 36,500 |
| 2016-03-01 | 1.2727 | 14 | 11 | 128,668 | 88,250 |
| 2015-12-01 | 0.6364 | 7 | 11 | 60,000 | 81,987 |
| 2015-09-01 | 1.5 | 18 | 12 | 227,736 | 56,565 |
| 2015-06-01 | 2.0 | 2 | 1 | 6,364 | 19,843 |
| 2015-03-01 | 2.0 | 2 | 1 | 9,280 | 3,000 |
| 2014-09-01 | 1.0 | 11 | 11 | 162,410 | 48,163 |
| 2014-06-01 | 0.4286 | 3 | 7 | 16,000 | 65,390 |
| 2014-03-01 | 0.4 | 10 | 25 | 60,500 | 187,095 |
| 2013-12-01 | 0.4615 | 12 | 26 | 68,384 | 249,684 |
| 2013-09-01 | 0.5926 | 16 | 27 | 179,415 | 187,996 |
| 2013-06-01 | 0.3438 | 11 | 32 | 74,899 | 239,705 |
| 2013-03-01 | 0.4167 | 5 | 12 | 20,000 | 156,107 |
| 2012-12-01 | 0.3667 | 11 | 30 | 90,000 | 255,317 |
| 2012-09-01 | 0.6 | 21 | 35 | 429,308 | 471,115 |
| 2011-09-01 | 1.0 | 14 | 14 | 219,074 | 76,659 |
| 2011-03-01 | 1.0 | 2 | 2 | 15,000 | 28,984 |
| 2010-09-01 | 2.5 | 25 | 10 | 596,871 | 47,683 |
| 2010-03-01 | 6.0 | 6 | 1 | 33,000 | 19,461 |
| 2009-09-01 | 3.1667 | 19 | 6 | 651,000 | 16,085 |
| 2008-09-01 | 9.0 | 27 | 3 | 527,201 | 5,361 |
| 2008-06-01 | 1.0 | 2 | 2 | 2,280 | 13,575 |
| 2008-03-01 | 7.0 | 7 | 1 | 552,000 | 21,450 |
| 2007-09-01 | 27.0 | 27 | 1 | 610,300 | 8,000 |
| 2006-12-01 | 1.0 | 1 | 1 | 5,000 | 20,000 |
| 2006-09-01 | 17.0 | 17 | 1 | 82,000 | 0.00 |
| 2006-06-01 | 2.5 | 10 | 4 | 397,899 | 32,000 |
| 2005-12-01 | 0.3636 | 4 | 11 | 112,000 | 217,026 |
| 2005-09-01 | 3.5 | 7 | 2 | 56,000 | 16,000 |
| 2004-06-01 | 1.3333 | 4 | 3 | 128,000 | 36,000 |
CAMP4 THERAPEUTICS Notable Stakeholders
A CAMP4 THERAPEUTICS stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as CAMP4 THERAPEUTICS often face trade-offs trying to please all of them. CAMP4 THERAPEUTICS's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting CAMP4 THERAPEUTICS's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Leonard MD | Founder | Profile | |
| Joshua MandelBrehm | President CEO | Profile | |
| Chris Adams | President CEO | Profile | |
| Maurizio Iperti | President Automotive | Profile | |
| Monica Berkel | Senior President | Profile | |
| Richard Vitelle | CFO, Executive VP, Corporate Secretary and Treasurer | Profile | |
| Jikun Kim | Senior CFO | Profile | |
| Richard Young | Founder Director | Profile | |
| Jeffery Gardner | Independent Director | Profile | |
| Daniel Tardiff | VP Discovery | Profile | |
| Kelly Gold | Chief Officer | Profile | |
| John Partain | Interim Experience | Profile | |
| Erik Schulz | Interim Officer | Profile | |
| Christian Horne | Interim Sales | Profile | |
| Brett Jackson | Senior Logistics | Profile | |
| Mark Gaydos | Chief Officer | Profile | |
| Michael Zachan | Senior Unit | Profile | |
| Nathan Lowstuter | Senior Officer | Profile | |
| Xiaolian Zhang | Senior Analysis | Profile | |
| Caleb Moore | Chief Operations | Profile | |
| David Bumcrot | Chief Research | Profile | |
| Michelle Gates | Senior Officer | Profile | |
| Richard Scott | Chief VP | Profile | |
| Scott Tripp | VP Operations | Profile | |
| MD MBA | Chief Officer | Profile | |
| Anand Rau | VP CTO | Profile | |
| Satya Kuchimanchi | Senior Operations | Profile |
About CAMP4 THERAPEUTICS Management Performance
The success or failure of an entity such as CAMP4 THERAPEUTICS often depends on how effective the management is. CAMP4 THERAPEUTICS management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of CAMP4 management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the CAMP4 management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.23) | (0.22) | |
| Return On Capital Employed | (0.04) | (0.05) | |
| Return On Assets | (0.16) | (0.15) | |
| Return On Equity | (0.57) | (0.54) |
CAMP4 THERAPEUTICS Workforce Analysis
Traditionally, organizations such as CAMP4 THERAPEUTICS use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare CAMP4 THERAPEUTICS within its industry.CAMP4 THERAPEUTICS Manpower Efficiency
Return on CAMP4 THERAPEUTICS Manpower
| Revenue Per Employee | 3.2M | |
| Revenue Per Executive | 6.9M | |
| Net Loss Per Employee | 849.8K | |
| Net Loss Per Executive | 1.8M | |
| Working Capital Per Employee | 555.3K | |
| Working Capital Per Executive | 1.2M |
Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.